Pemphigus Completed Phase 3 Trials for Rituximab (DB00073)

IndicationStatusPhase
DBCOND0001806 (Pemphigus)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01299857Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab